We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NBY market cap is 574.58k. The company's latest EPS is USD -2.5572 and P/E is -0.04.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.09M | 3.64M | 3.12M | 4.61M | 3.27M |
| Operating Income | -457k | -9.43M | -1.73M | -1.36M | -1.12M |
| Net Income | -5.79M | -8.21M | -1.74M | -4.03M | -1.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.6M | 9.93M | 8.42M | 14.4M | 14.73M |
| Operating Income | -9.4M | -6.43M | -8.86M | -14.42M | -7.6M |
| Net Income | -10.46M | -11.04M | -6.56M | -16.27M | -16.7M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 22.38M | 16.4M | 14.83M | 16.01M | 12.85M |
| Total Liabilities | 8.59M | 5.85M | 5.94M | 7.45M | 5.82M |
| Total Equity | 13.78M | 10.55M | 8.89M | 8.56M | 7.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.22M | 15.24M | 23.98M | 16.4M | 9.03M |
| Total Liabilities | 10.25M | 2.92M | 13.81M | 5.85M | 5.72M |
| Total Equity | 973k | 12.32M | 10.17M | 10.55M | 3.31M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.45M | -6.65M | -1.61M | -3.45M | -3.82M |
| Investing | -112k | -112k | -13k | -15k | -17k |
| Financing | 1.6M | 4.63M | N/A | 2.51M | 1.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.93M | -4.72M | -9.19M | -6.65M | -4.13M |
| Investing | -19k | -26k | -12.05M | -112k | -19k |
| Financing | 11.7M | 9.76M | 16.79M | 4.63M | 1.91M |
| Market Cap | 574.58k |
| Price to Earnings Ratio | -0.04 |
| Price to Sales Ratio | 0.04 |
| Price to Cash Ratio | 0.19 |
| Price to Book Ratio | 0.18 |
| Dividend Yield | - |
| Shares Outstanding | 6.53M |
| Average Volume (1 week) | 1.27M |
| Average Volume (1 Month) | 2.24M |
| 52 Week Change | -92.35% |
| 52 Week High | 1.28 |
| 52 Week Low | 0.065 |
| Spread (Intraday) | 0 (4.86%) |
| Company Name | NovaBay Pharmaceuticals Inc New |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.novabay.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
